The size of the Europe Antacid Market value was worth USD 3.99 billion in 2020. It is further estimated to be growing at a CAGR of 4.3% and value USD 4.93 billion by 2025.
Antacids are a group of medications that help neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion, and other symptoms are nausea, bloating, or belching. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. A few people have announced unfavorably susceptible responses to antacids.
The growing trend toward self-medication is increasing the demand for over-the-counter digestive products to treat gastrointestinal disorders. Antacids are used to neutralize acidity and should therefore cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect, and allergic reactions. Also, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.
This research report on the Europe Antacid Market segmented and sub-segmented into the following categories and evaluated market size and forecast until 2025:
By Drug Class:
By Formulation Type:
By Distribution Channel:
By Country:
The market is segmented into the UK, Spain, Germany, France, and others by geography. It is occupying last second place in terms of market share. Among them, the UK and Germany have occupied the highest share. German has many investments compared to other regions.
Some of the Prominent Companies leading the European Antacid Market profiled in this report are GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc., Sun Pharma, Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Submarkets
5.1.1 Introduction
5.1.2 Chromatography
5.1.3 E-Clinical Trial Solutions
5.1.4 Wireless Health, Clinical Trial Management Systems(CTMS)
5.1.5 Healthcare IT outsourcing
5.1.6 Immunoassay
5.1.7 Digital Pathology
5.1.8 Next Generation sequencing(NGS)
5.1.9 Proteomics
5.1.10 Magnesium Compounds
5.1.11 , Aluminium Compounds
5.1.12 Calcium Compounds
5.1.13 Antacids with Antiflatulents
5.1.14 Y-o-Y Growth Analysis, By Submarkets
5.1.15 Market Attractiveness Analysis, By Submarkets
5.1.16 Market Share Analysis, By Submarkets
5.2 Application
5.2.1 Introduction
5.2.2 Novel Dietary Fibers
5.2.3 Y-o-Y Growth Analysis, By Application
5.2.4 Market Attractiveness Analysis, By Application
5.2.5 Market Share Analysis, By Application
5.3 Ingredients
5.3.1 Introduction
5.3.2 Protease
5.3.3 Modified Starch
5.3.4 Food & Beverage Starch
5.3.5 Gellatin
5.3.6 Collagen
5.3.7 Carbohydrase
5.3.8 Food & Beverage Sugars & its substitutes
5.3.9 Y-o-Y Growth Analysis, By Ingredients
5.3.10 Market Attractiveness Analysis, By Ingredients
5.3.11 Market Share Analysis, By Ingredients
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Submarkets
6.1.3.3 By Application
6.1.3.5 By Ingredients
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Submarkets
6.1.4.3 By Application
6.1.4.4 By Ingredients
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Submarkets
6.1.5.3 By Application
6.1.5.4 By Ingredients
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 First Aid Only
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GSK
8.3 WellSpring Pharm
8.4 Private Lable
8.5 Pfizer
8.6 Procter & Gamble
8.7 Glaxosmithkline
8.8 Boehringer Ingellheim Pharm
8.9 Novaritis Consurmer Health
8.10 Johnson & Johnson
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
